Section Arrow
BIVI.NASDAQ
- BioVie
(Financial Status)
Quotes are at least 15-min delayed:2024/05/03 09:34 EDT
Last
 0.495
-0.0049 (-0.98%)
Day High 
0.50175 
Prev. Close
0.4999 
1-M High
0.5499 
Volume 
44.73K 
Bid
0.49
Ask
0.501
Day Low
0.49 
Open
0.5 
1-M Low
0.445 
Market Cap 
27.46M 
Currency USD 
P/E -- 
%Yield
10-SMA 0.49 
20-SMA 0.49 
50-SMA 0.68 
52-W High 8.69 
52-W Low 0.445 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.17/-1.30
Enterprise Value
32.73M
Balance Sheet
Book Value Per Share
0.14
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
JAGXJaguar Health0.3492+0.056+19.10%-- 
VAXXVaxxinity0.1362+0.032+30.71%-- 
ARDXArdelyx8.3183+1.5283+22.51%-- 
CTMXCytomX Therapeutics4.6799+0.1799+4.00%-- 
ALLRAllarity Therapeutics1.145-0.085-6.91%-- 
Quotes are at least 15-min delayed:2024/05/03 09:34 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
BioVie Inc is a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting apotentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.